Cytori Therapeutics, Inc. (CYTX) Misses Q4 EPS by 2c
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q4 EPS of ($0.14) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)